N-hydroxyarylamines

Drug Metabolism Reviews

Volumn 34, Issue 3, 2002, Pages 607-623

  Guengerich, F Peter ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arylamines; Cytochrome P450, in activation of arylamines; DNA adducts from, N hydroxyarylamines; Heterocyclic amines; Mutagenicity assays; N Hydroxyarylamines, formation and reactions of

Indexed keywords

AROMATIC AMINE; CARCINOGEN; CYTOCHROME P450; DNA; ESTER; HETEROCYCLIC AMINE; AMINE; GUANINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE;

CARCINOGENICITY; CHEMOPROPHYLAXIS; CONFERENCE PAPER; HUMAN; MUTAGENICITY; NONHUMAN; OXIDATION; SCREENING; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; ENZYME ACTIVATION; ESCHERICHIA COLI; GENETICS; METABOLISM; MOLECULAR GENETICS; MUTAGEN TESTING; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION REACTION; REVIEW;

AMINES; BASE SEQUENCE; CYTOCHROME P-450 ENZYME SYSTEM; DNA; ENZYME ACTIVATION; ESCHERICHIA COLI; GUANINE; HUMANS; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; MUTAGENICITY TESTS; NADPH-FERRIHEMOPROTEIN REDUCTASE; OXIDATION-REDUCTION;

EID: 0036041122     PISSN: 03602532     EISSN: None     Source Type: Journal    
DOI: 10.1081/DMR-120005663     Document Type: Conference Paper

References (70)

1. Ueber blasentumoren bei fuchsinarbeitem
2. Carcinogenic aromatic amines and related compounds
3. Experimental production of bladder tumors in dogs by administration of beta-naphthylamine
4. On the protective action of certain polycyclic aromatic hydrocarbons against carcinogenesis by aminoazo dyes and 2-acetylaminofluorene
5. Orientation of biochemical hydroxylation in aromatic compounds
6. Activation and detoxification of N-2-fluorenylacetamide in man
7. Mutagens, carcinogens, and tumor promoters in our daily food
8. Reactions catalyzed by the cytochrome P450 system
9. The genotoxicity, metabolism and carcinogenicity of nitrated polycyclic aromatic hydrocarbons
10. Aerobic and anaerobic reduction of nitrated pyrenes in vitro
11. Inactivation of 1,3-, 1,6-, and 1,8-dinitropyrene by human and rat microsomes
12. From adenine to xanthates: An aromatic view
13. Evidence for the existence of distinct nitroreductases in salmonella typhimurium: Roles in mutagenesis
14. The role of cytochrome P-450 in the metabolism of chemical carcinogens
15. Cytochrome P-450 and flavin-containing monooxygenase-catalyzed formation of the carcinogen N-hydroxy-2-aminofluorene, and its covalent binding to nuclear DNA
16. Metabolic oxidation of carcinogenic arylamines by rat, dog, and human hepatic microsomes and by purified flavin-containing and cytochrome P-450 monooxygenases
17. Mechanism of formation and structural characterization of DNA adducts derived from peroxidative activation of benzidine
18. DNA adducts formed by ring-oxidation of the carcinogen 2-naphthylamine with prostaglandin H synthase in vitro and in the dog urothelium in vivo
19. Partitioning between N-dealkylation and N-oxygenation in the oxidation of N,N-dialkylarylamines catalyzed by cytochrome P450 2B1
20. Mechanisms of cytochrome P-450 catalysis
21. Sequential electron transfer reactions catalyzed by cytochrome P-450 enzymes
22. Mechanism of C8 alkylation of guanyl residues by activated arylamines: Evidence for a role of initial attack at the N7 atom
23. Peroxo-iron and oxenoid-iron species as alternative oxygenating agents in cytochrome P450-catalyzed reactions: Switching by threonine-302 to alanine mutagenesis of cytochrome P450 2B4
24. Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity
25. 3+, in N-oxygenation of amines by cytochrome P450 enzymes
26. 2 atoms of guanine and at the N6 atom of adenine
27. Metabolic activation and DNA adducts of aromatic amines and nitroaromatic hydrocarbons
28. 7-aminoguanosine and derivatives
29. 4-(Guanosin-7-yl)-4-aminoquinoline 1-oxide and its possible role in guanine C8 adduction
30. Rapid release of carcinogen-guanine adducts from DNA after reaction with N-acetoxy-2-acetylaminofluorene or N-benzoyloxy-N-methyl-4-aminoazobenzene
31. Estimation of apurinic/apyrimidinic sites and phosphotriesters in deoxyribonucleic acid treated with electrophilic carcinogens and mutagens
32. 8-Aminoguanine: A base modification produced in rat liver nucleic acids by the hepatocarcinogen 2-nitropropane
33. Characterization and properties of the DNA adducts formed from N-methyl-4-aminoazobenzene in rats during a carcinogenic treatment regimen
34. Electrophilic amination of imidazole moieties of 9-ethylguanine and 1-methylbenzimidazole derivatives and reactivities of N-aminated products
35. Structural identification of the pyrimidine derivatives formed from N-(Deoxyguanosin-8-yl)-2-aminofluorene in aqueous solution at alkaline pH
36. Direct O-acetylation of N-hydroxy arylamines by acetylsalicyclic acid to form carcinogen-DNA adducts
37. Aminations of guanosine and deoxyguanosine with hydroxylamine-O-sulfonic acid and 2,4-dinitrophenoxyamine. Dependence on the reaction medium
38. Electrophilic amination of guanine derivatives. Mechanism for formation of 8-aminoguanine derivatives
39. Synthesis of 7-aminoguanosine and its conversion of 8-substituted derivatives
40. Nucleophilic substitution on carcinogenic N-acetoxy-N-arylacetamides
41. Selective trapping of N-acetyl-N-(4-biphenyl)nitrenium and N-acetyl-N-(2-fluorenyl)nitrenium Ions by 2′-deoxyguanosine in aqueous solution
42. Reactions of ester derivatives of carcinogenic N-(4-Biphenyl)hydroxylamine and the corresponding hydroxamic acid with purine nucleosides
43. Spectroscopic characterization of the initial C8 intermediate in the reaction of the 2-fluorenylnitrenium ion with 2′-deoxyguanosine
44. Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA1535/pSK1002
45. PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines
46. Differences in activation of heterocyclic aromatic amines by rat and human liver microsomes and by rat and human cytochromes P450 1A2
47. 8 and N-oxidation of 2-amino-3,8-dimethylimidazo[4.5-f]quinoxaline by human and rat liver microsomes and cytochromes P450 1A2
48. Recombinant human cytochrome P450 1B1 expression in Escherichia coli
49. Activation of chemically diverse procarcinogens by human cytochrome P450 1B1
50. Metabolic activation of heterocyclic amines and other procarcinogens in salmonella typhimurium umu tester strains expressing human cytochrome P450 1A1 1A2, 1B1, 2C9, 2D6, 2E1, and 3A4 and human NADPH-P450 reductase and bacterial O-acetyltransferase
51. Human fetal liver cytochrome P-450: Capacity to form genotoxic metabolites
52. Pyrolysis products from amino acids and protein: Highest mutagenicity requires cytochrome P1-450
53. Hair dyes are mutagenic: Identification of a variety of mutagenic ingredients
54. New tester strains of Salmonella typhimurium highly sensitive to mutagenic nitroarenes
55. Recent advances in the construction of bacterial genotoxicity assays
56. Bioactivation of aromatic amines by recombinant human cytochrome P450 1A2 expressed in bacteria: A substitute for mammalian tissue preparations in mutagenicity testing
57. Drug metabolism by Escherichia coli expressing human cytochromes P450
58. Metabolic activation of aromatic amine mutagens by simultaneous expression of human cytochrome P450 1A2, NADPH-cytochrome P450 Reductase, and N-Acetyltransferase in Escherichia coli
59. Expression of human cytochrome P450 1A2 in Escherichia coli: A system for biotransformation and genotoxicity studies of chemical carcinogens
60. Establishment of a Salmonella tester strain highly sensitive to mutagenic heterocyclic amines
61. Development of a new genotoxicity test system with Salmonella typhimurium OY1001/1A2 expressing human cytochrome P450 1A2 and NADPH-cytochrome P450 reductase
62. Use of genetically engineered Salmonella typhimurium OY1002/1A2 strain co-expressing human cytochrome P450 1A2 and NADPH-cytochrome P450 reductase and bacterial O-acetyltransferase in SOS/umu Assay
63. SOS-inducing activity of chemical carcinogens and mutagens in Salmonella typhimurium TA1535/pSK1002: Examination with 151 chemicals
64. SOS function tests for studies of chemical carcinogenesis in Salmonella typhimurium TA 1535/pSK1002, NM2009, and NM3009
65. Selection and characterization of human cytochrome P450 1A2 mutants with altered catalytic properties
66. Rate-determining steps in phenacetin oxidations by human cytochrome p450 1A2 and selected mutants
67. Oxidations of p-alkoxyacylanilides by human cytochrome P450 1A2
68. Inhibition of human cytochrome P450 enzymes by 1,2-dithiole-3-thione, oltipraz and its derivatives, and sulforaphane
69. A new selective potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis